[1]
S. Dulal, “Outcome of Epidermal Growth Factor Receptor Mutated and Non Mutated Adenocarcinoma Lung to Standard Therapy”, J Nepal Health Res Counc, vol. 21, no. 2, pp. 330-335, Dec. 2023.